+66.7%
XLI vs CVS
+11.5%
+55.2%
-21.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -0.9% | -1.0% | -1.7% |
| 7D | -1.9% | +3.9% | -5.8% | -2.5% |
| 30D | -1.3% | -3.4% | +2.1% | -0.9% |
| 3M | -10.9% | -8.2% | -2.8% | -10.0% |
| 6M | -2.9% | -6.4% | +3.5% | -2.2% |
| YTD | +7.6% | +15.1% | -7.4% | +3.9% |
| 1Y | +10.2% | +17.4% | -7.1% | +5.9% |
| 3Y | +64.6% | +45.3% | +19.3% | +48.5% |
| 5Y | +66.7% | +12.7% | +54.0% | +60.1% |
| All | +66.7% | +11.5% | +55.2% | +60.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling